Enzalutamide — Dosing in CKD & Dialysis
Enzalutamide (Antineoplastic): renal dosing adjustments, dialyzability (Not studied in the label (no statement on removal by dialysis); enzalutamide is 97% to 98% bound to plasma proteins and N-desmethyl enzalutamide 95% (Xtandi label 12.3), and in one hemodialysis patient their plasma levels were i
Reviewed by Matt · November 16, 2026